期刊
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
卷 58, 期 15, 页码 4901-4905出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201813149
关键词
cytotoxicity; hepatocellular carcinoma; peptides; platinum nanoparticles; selectivity
资金
- European Union [705970]
- Swiss National Science Foundation [CRSII2 160805]
- Swiss National Science Foundation (SNF) [CRSII2_160805] Funding Source: Swiss National Science Foundation (SNF)
- Marie Curie Actions (MSCA) [705970] Funding Source: Marie Curie Actions (MSCA)
Peptide-stabilized platinum nanoparticles (PtNPs) were developed that have significantly greater toxicity against hepatic cancer cells (HepG2) than against other cancer cells and non-cancerous liver cells. The peptide H-Lys-Pro-Gly-dLys-NH2 was identified by a combinatorial screening and further optimized to enable the formation of water-soluble, monodisperse PtNPs with average diameters of 2.5 nm that are stable for years. In comparison to cisplatin, the peptide-coated PtNPs are not only more toxic against hepatic cancer cells but have a significantly higher tumor cell selectivity. Cell viability and uptake studies revealed that high cellular uptake and an oxidative environment are key for the selective cytotoxicity of the peptide-coated PtNPs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据